Mei Baker, MD, FACMG is a professor in the Department of Pediatrics, and Director in the Newborn Screening Laboratory at the University of Wisconsin School of Medicine and Public Health.
Dr. Baker practiced medicine before being trained in both biochemical and molecular genetics, obtaining a clinical biochemical genetics certification from the American Board of Medical Genetics and Genomics in 2009. She has 15 years of experience in routine newborn screening (NBS) with specific interest in, and a successful track record of, applying emerging technologies to implement new screening tests for disorders and to improve ongoing screening tests. She is one of the leading scientists who made Wisconsin the first state in the nation and the world to implement universal NBS for severe combined immunodeficiency (SCID) in 2008. She has developed and implemented cystic fibrosis NBS using next generation sequencing technology in the Wisconsin NBS program. Dr. Baker’s contribution to science has been widely recognized, as evidenced by receiving the Harry Hannon Laboratory Improvement Award in Newborn Screening from the Association of Public Health Laboratories.
Dr. Baker served as a member of the Advisory Committee on Heritable Disorders in Newborns and Children from 2016 to 2021, and served as a member of the Newborn Screening Committee at the Association of Public Health Laboratories (APHL) from 2015-2022. She is a council member of the International Society for Neonatal Screening (ISNS).